The US Food and Drug Administration (FDA) has approved Sun Pharmaceutical Industries' abbreviated new drug application (ANDA) for Doxorubicin HCl Liposome Injection USP, 2 mg/ml. Doxorubicin HCl Liposome Injection USP, 2 mg/ml, which is ...
Tags: FDA, Sun Pharma, Pharmaceutical
DNA from cervical screening samples could be used to identify ovarian and womb cancers, a study has suggested. The Press Association has reported that scientists from John Hopkins Medical Institutes extended the screening programme's DNA ...
Tags: DNA, cervical screening samples, ovarian and womb cancers
The analysis of DNA mutations in patients with cancer can be carried out without surgery. This is according to new research from AACC's Clinical Chemistry journal, which demonstrated that the plasma of cancer patients also includes ...
Tags: DNA mutations, cancer, surgery, Clinical Chemistry
MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
Roche has announced the US launch of automated Elecsys HE4 assay, designed as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The assay, which is approved for use on the Elecsys ...
Tags: epithelial ovarian cancer, clinical technology, clinical trial
Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases,such as cancer and Alzheimer's,3 million times more sensitive. That means what researchers are calling a breakthrough in nanotechnology ...
Tags: nanotechnology, detect diseases, Princeton University, D2PA, Cancer
Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML
Immunovaccine has reported a net loss of $1.7m for the third quarter ended 30 September 2012 compared to a net loss of $1.5m for the same quarter in 2011. According to the company the increased loss is due to the $155,000 increase in ...
Tags: Net Loss, therapeutic cancer vaccine, immune enhancement technology
MONTEVALLO, Ala.- Summer Classics, a leading outdoor furniture manufacturer and retailer, celebrated its annual Garden Party, Aug. 6-10. The weeklong event allowed customers to view the company's six new collections, additions to existing ...
Tags: outdoor furniture
Vermillion has received a notice of allowance from the United States Patent and Trademark Office for a patent entitled, Biomarkers for Ovarian Cancer. The patent makes claims in the uses of a urinary Small MBL-associated protein ...